Albany, NY -- (SBWIRE) -- 12/24/2014 -- Biliary cirrhosis is an autoimmune disease of the kidney that results in the damage of small bile ducts of the liver, caused due to build-up of bile within the liver. The pressure formed by the accumulation of bile leads to severe liver cell damage. Due to weak immune systems, bile ducts are damaged accompanied with higher levels of bile in the liver, finally resulting into cirrhosis. The various symptoms associated with biliary cirrhosis are as follows:

- Fatigue
- Itchiness of the skin
- Dry mouth and eyes
- Abdominal pain
- Yellowing of skin
- Vaginal dryness

Early buyers will receive 10% customization on reports :
http://www.transparencymarketresearch.com/biliary-cirrhosis-market.html

The diagnosis of biliary cirrhosis is done through various liver function tests such as aspartate aminotransferase (AST), alanine aminotransferase (ALT), alkaline phosphatase, bilirubin, complete blood count (CBC) and cholesterol level tests. Other imaging tests include ultrasound, magnetic resonance imaging (MRI), and computerized tomography.

Based on treatment, the biliary cirrhosis market can be segmented as follows:

- Ursodeoxycholic acid (UDCA): UDCA is a bile acid that helps in smooth movement of bile in the liver. UDCA does not primarily cure biliary cirrhosis but is considered the first line of therapy as the treatment reduces the need for a liver transplant. Side-effects of this treatment include weight gain, vomiting, nausea and hair loss.

- Corticosteroids: Corticosteroids contain steroids that suppress an individual's immune system in order to reduce inflammation. For instance, prednisolone.

- Liver transplant: In case of total liver failure, liver transplant may be performed. Administration of immunosuppressants is necessary after liver transplantation as the immune system may reject the donated liver.

- Treatment for itchiness: Treatment of itchiness associated with biliary cirrhosis is usually treated with a drug, colestyramine.

Geographically, the biliary cirrhosis market is segmented into four major regions: North America, Europe, Asia Pacific and Rest of the World (RoW). Europe holds the leading position in the market followed by North America. The factors which are driving the growth of biliary cirrhosis market are rapidly increasing women population with biliary cirrhosis, and increasing demand for sophisticated advanced testing tools and diagnostics. Furthermore, increasing sedentary habits such as smoking, drinking and use of tobacco are also considered to increase the risk of biliary cirrhosis among the population. According to a study, the prevalence of biliary cirrhosis has been estimated as 12.9 per 100,000 population with 90% of the cases occurring in women. Asia Pacific is one of the fastest growing regions for the growth of biliary cirrhosis market. The beneficial factors that will boost the growth of the biliary cirrhosis treatment market in Asia Pacific are increasing population base, rise in the number of weakened immune systems especially among the female geriatric population and growing awareness of people in developing nations about the available treatment options. Moreover, other factors such as tax benefits, easy market penetration and favorable reimbursement policies would also augment the growth of the market in the next few years.

At present, various pharmaceutical companies are coming up with novel and advanced therapeutics for the development of biliary cirrhosis market. Some of the top players operating in biliary cirrhosis market are Pfizer, Inc., Teva Pharmaceuticals USA, Inc., GlaxoSmithKline plc, Johnson & Johnson, Intercept Pharmaceuticals, Inc, Lumena Pharmaceuticals, Inc. and many others.

More Reports on Pharmaceutical Market :
http://www.transparencymarketresearch.com/pharmaceutical-market-reports-1.html

This research report analyzes this market depending on its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

- North America
- Asia Pacific
- Europe
- Rest of the World

This report provides comprehensive analysis of:

- Market growth drivers
- Factors limiting market growth
- Current market trends
- Market structure
- Market projections for upcoming years

This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter's five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

Enquiry Before Buying :
http://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3166

About Transparency Market Research
Transparency Market Research is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers.

Contact:
Transparency Market Research
90 State Street,
Suite 700,
Albany
NY - 12207
United States
Tel: 518-618-1030
USA - Canada Toll Free 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

Browse Market Research Blog:
http://pharmaceuticalresearchreport.blogspot.com/